The 5th Shenzhen International Brand Week opens: Beike Biotech wins two honors!

Brands are an important reflection of an enterprise's and a country's competitiveness, and a key resource for winning the global market. China's "14th Five-Year Plan" and the Outline of Long-Range Objectives for 2035 call for promoting manufacturing sector products to "expand product variety, raise quality and create brands", launching a China brand-building action, enhancing the influence and competitiveness of homegrown brands and cultivating a group of high-end brands. General Secretary Xi Jinping has also said: "We must drive the transition from China speed to China quality, from Made in China to Created in China, and from Chinese products to Chinese brands."

On 11 May, the 2021 China Brand Day Shenzhen Local Special Event and 5th "Shenzhen International Brand Week" event was grandly launched at the broadcasting hall of the Shenzhen Radio and Television Building. Beike Biotech received two honors – "Shenzhen Famous Brand" and "Leading Enterprise in China's Cell Field" – with Dr. Hu Junyuan, Chairman of Beike Biotech, invited to receive the awards. He also attended the 2021 Greater Bay Area Quality and Brand Summit and joined the roundtable dialogue, where he discussed brand innovation and breakthrough strategies in the digital age with the guests in attendance.

With sixteen years of work in the cell field and years of brand building, Beike Biotech stood out from hundreds of candidate enterprises to win the honors of "Shenzhen Famous Brand" and "Leading Enterprise in China's Cell Field", with its brand strength formally recognized.

Beike Biotech has a specialized R&D team led by multiple experts of outstanding achievement in the cell field and by domestic and international scholars. The company has consistently let professionalism and quality speak for it, upholding its core corporate values of "loyalty, responsibility, rigor, innovation, care, service, teamwork and communication", putting innovation at the top of its priorities, continuously deepening product technology R&D capability, rigorously controlling product quality, and earning visibility and reputation through its rigorous and meticulous approach. The company has become a backbone force in China's stem cell clinical research field that cannot be ignored.

The development of biotechnology bears on the national economy and people's livelihoods, and on the country's future competitiveness. Amid the sudden COVID-19 outbreak in 2020, stem cells – especially mesenchymal stem cells (MSCs) – stood out in research on treating severe and critical cases. Cell therapy technology has thus encountered new opportunities for development. On the topic of "how brands can innovate in the digital age", Dr. Hu Junyuan, Chairman of Beike Biotech, was invited to attend the 2021 Greater Bay Area Quality and Brand Summit and joined the roundtable dialogue, sharing Beike Biotech's path to breakthrough in light of the current situation.